Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zhang, Jian ^a   Shan, Wei Feng ^a   Jin, Te Te ^a   Wu, Guo Qing ^b   Xiong, Xiao Xing ^a   Jin, Hai Yan ^c   Zhu, Sheng Mei ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatocellular carcinoma; Microvesicles; miR 142 3p; Propofol; RAC1

Indexed keywords

MICRORNA; MICRORNA 142 3P; PROPOFOL; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN142 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; IN VIVO STUDY; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; RNA TRANSPORT; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; BLOOD; C57BL MOUSE; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; COCULTURE; DRUG EFFECTS; HUMAN; LIVER NEOPLASMS; MACROPHAGE; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL-DERIVED MICROPARTICLES; COCULTURE TECHNIQUES; HUMANS; LIVER NEOPLASMS; MACROPHAGES; MALE; MICE, INBRED C57BL; MICRORNAS; PROPOFOL;

EID: 84925230661     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-014-0279-x     Document Type: Article

References (30)

1. Gomes MA, Priolli DG, Tralhão JG, Botelho MF: Hepatocellular carcinoma: epidemiology, biology, diagnosis, and therapies. Rev Assoc Med Bras 2013, 59(5):514-524.
2. Herszényi L, Tulassay Z: Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010, 14(4):249-258.
3. Wang J, He XD, Yao N, Liang WJ, Zhang YC: A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma. Can J Gastroenterol 2013, 27(6):351-363.
4. Chan DL, Morris DL, Chua TC: Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-a systematic review. Surg Oncol 2013, 22(2):e23-e30.
5. Gluer AM, Cocco N, Laurence JM, Johnston ES, Hollands MJ, Pleass HC, Richardson AJ, Lam VW: Systematic review of actual 10-year survival following resection for hepatocellular carcinoma. HPB (Oxford) 2012, 14(5):285-290.
6. Zhou XD: Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int 2002, 1(1):35-41.
7. Ren XF, Li WZ, Meng FY, Lin CF: Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia 2010, 65(5):478-482.
8. Miyata T, Kodama T, Honma R, Nezu Y, Harada Y, Yogo T, Hara Y, Tagawa M: Influence of general anesthesia with isoflurane following propofolinduction on natural killer cell cytotoxic activities of peripheral blood lymphocytes in dogs. J Vet Med Sci 2013, 75(7):917-921.
9. Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T, Kishi Y, Nakamura H: Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 2002, 184(2):165-170.
10. Tsuchiya M, Asada A, Arita K, Utsumi T, Yoshida T, Sato EF, Utsumi K, Inoue M: Induction and mechanism of apoptotic cell death by propofol in HL-60 cells. Acta Anaesthesiol Scand 2002, 46(9):1068-1074.
11. Miao Y, Zhang Y, Wan H, Chen L, Wang F: GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomed Pharmacother 2010, 64(9):583-588.
12. Inada T, Kubo K, Shingu K: Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol. J Anesth 2011, 25(4):569-575.
13. Zhang J, Zhang D, Wu GQ, Feng ZY, Zhu SM: Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA- 199a and downregulating MMP-9 expression. Hepatobiliary Pancreat Dis Int 2013, 12(3):305-309.
14. Zhang J, Wu GQ, Zhang Y, Feng ZY, Zhu SM: Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression. Cell Biol Int 2013, 37(3):227-232.
15. Hung CH, Chiu YC, Chen CH, Hu TH: MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int 2014, 2014:486407.
16. Sun J, Lu H, Wang X, Jin H: MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. Sci World J 2013, 2013:924206.
17. Li W, Xie L, He X, Li J, Tu K, Wei L, Wu J, Guo Y, Ma X, Zhang P, Pan Z, Hu X, Zhao Y, Xie H, Jiang G, Chen T, Wang J, Zheng S, Cheng J, Wan D, Yang S, Li Y, Gu J: Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008, 123(7):1616-1622.
18. Gailhouste L, Ochiya T: Cancer-related microRNAs and their role as tumor suppressors and oncogenes inhepatocellular carcinoma. Histol Histopathol 2013, 28(4):437-451.
19. Wu L, Cai C, Wang X, Liu M, Li X, Tang H: MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett 2011, 585(9):1322-1330.
20. Sonda N, Simonato F, Peranzoni E, Calì B, Bortoluzzi S, Bisognin A, Wang E, Marincola FM, Naldini L, Gentner B, Trautwein C, Sackett SD, Zanovello P, Molon B, Bronte V: miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity 2013, 38(6):1236-1249.
21. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C: Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010, 123(Pt 10):1603-1611.
22. Morello M, Minciacchi VR, de Candia P, Yang J, Posadas E, Kim H, Griffiths D, Bhowmick N, Chung LW, Gandellini P, Freeman MR, Demichelis F, Di Vizio D: Large oncosomes mediate intercellular transfer of functional microRNA. Cell Cycle 2013, 12(22):3526-3536.
23. Yang M, Chen J, Su F, Yu B, Su F, Lin L, Liu Y, Huang JD, Song E: Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs intobreast cancer cells. Mol Cancer 2011, 10:117.
24. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q, Wang K, Ba Y, Wang Q, Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K, Zhang CY: Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010, 39(1):133-144.
25. Hara M, Kono H, Furuya S, Hirayama K, Tsuchiya M, Fujii H: Macrophage colony-stimulating factor plays a pivotal role in chemically induced hepatocellular carcinoma in mice. Hepatol Res 2013, [Epub ahead of print].
26. Yuan A, Chen JJ, Yang PC: Pathophysiology of tumor-associated macrophages. Adv Clin Chem 2008, 45:199-223.
27. D'Souza-Schorey C, Clancy JW: Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012, 26(12):1287-1299.
28. Antonyak MA, Cerione RA: Microvesicles as mediators of intercellular communication in cancer. Methods Mol Biol 2014, 1165:147-173.
29. Wu J, Meng J, Du Y, Huang Y, Jin Y, Zhang J, Wang B, Zhang Y, Sun M, Tang J: RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway. Biomed Pharmacother 2013, 67(4):313-319.
30. Yang W, Lv S, Liu X, Liu H, Yang W, Hu F: Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma. Jpn J Clin Oncol 2010, 40(11):1053-1059.